Literature DB >> 10509192

TGF-beta and bFGF affect the differentiation of proliferating porcine fibroblasts into myofibroblasts in vitro.

I M Khouw1, P B van Wachem, J A Plantinga, Z Vujaskovic, M J Wissink, L F de Leij, M J van Luyn.   

Abstract

Fibroblasts and myofibroblasts are involved in the foreign body reaction to biomaterials, especially in capsule formation. However, contraction or detachment of the capsule can lead to complications. Biocompatibility of biomaterials may be improved by the application of proteins regulating the differentiation or activation of (myo)fibroblasts. Myofibroblasts, differentiating from fibroblasts can be identified by the expression of alpha-smooth muscle actin (alpha-SM actin). We investigated the influence of proliferation and quiescence on the differentiation of porcine dermal cells and whether transforming growth factor-beta (TGF-beta) and basic fibroblast growth factor (bFGF) are involved in the differentiation of proliferating cells. Porcine cells were used because pigs increasingly function as in vivo models while little is known of the characteristics of their cells. Serum-free cultured, quiescent fibroblasts differentiated into myofibroblasts, while proliferating fibroblasts cultured in the presence of serum containing TGF-beta, formed alpha-SM actin-negative cell clusters. After reaching confluency, these clusters started to expressing alpha-SM actin. Moreover, these proliferating cells produced TGF-beta from day 4 onwards while bFGF did not. Differentiation into myofibroblasts was inhibited by bFGF and to an even greater extent by antibodies to TGF-beta. Further, two theories concerning the role of the myofibroblast in tissue contraction in view of two biomaterial application will be discussed.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10509192     DOI: 10.1016/s0142-9612(99)00077-0

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  14 in total

Review 1.  Targeting cardiac fibroblasts to treat fibrosis of the heart: focus on HDACs.

Authors:  Katherine B Schuetze; Timothy A McKinsey; Carlin S Long
Journal:  J Mol Cell Cardiol       Date:  2014-03-11       Impact factor: 5.000

Review 2.  Fine-tuning vascular fate during endothelial-mesenchymal transition.

Authors:  Lin Xiao; Andrew C Dudley
Journal:  J Pathol       Date:  2016-11-10       Impact factor: 7.996

Review 3.  Ca2+ signalling in fibroblasts and the therapeutic potential of KCa3.1 channel blockers in fibrotic diseases.

Authors:  Katy M Roach; Peter Bradding
Journal:  Br J Pharmacol       Date:  2020-02-03       Impact factor: 8.739

4.  The cxc chemokine cCAF stimulates differentiation of fibroblasts into myofibroblasts and accelerates wound closure.

Authors:  Jo Ellen Feugate; QiJing Li; Lina Wong; Manuela Martins-Green
Journal:  J Cell Biol       Date:  2002-01-07       Impact factor: 10.539

Review 5.  The role of myofibroblasts in wound healing, contraction and its clinical implications in cleft palate repair.

Authors:  Ravi Teja Chitturi; A Murali Balasubramaniam; R Arjun Parameswar; G Kesavan; K T Muhamed Haris; Khadijah Mohideen
Journal:  J Int Oral Health       Date:  2015-03

6.  Human lung myofibroblast TGFβ1-dependent Smad2/3 signalling is Ca(2+)-dependent and regulated by KCa3.1 K(+) channels.

Authors:  Katy M Roach; Carol Feghali-Bostwick; Heike Wulff; Yassine Amrani; Peter Bradding
Journal:  Fibrogenesis Tissue Repair       Date:  2015-03-26

7.  Fully Dedifferentiated Chondrocytes Expanded in Specific Mesenchymal Stem Cell Growth Medium with FGF2 Obtains Mesenchymal Stem Cell Phenotype In Vitro but Retains Chondrocyte Phenotype In Vivo.

Authors:  Jungsun Lee; Jin-Yeon Lee; Byung-Chul Chae; Jeongho Jang; EunAh Lee; Youngsook Son
Journal:  Cell Transplant       Date:  2017-10       Impact factor: 4.064

Review 8.  Strategies Demonstrating Efficacy in Reducing Wound Contraction In Vivo.

Authors:  Justin R Sharpe; Yella Martin
Journal:  Adv Wound Care (New Rochelle)       Date:  2013-05       Impact factor: 4.730

9.  Reversible modulation of myofibroblast differentiation in adipose-derived mesenchymal stem cells.

Authors:  Vivek D Desai; Henry C Hsia; Jean E Schwarzbauer
Journal:  PLoS One       Date:  2014-01-23       Impact factor: 3.240

10.  Reversible and irreversible differentiation of cardiac fibroblasts.

Authors:  Ronald B Driesen; Chandan K Nagaraju; Joëlle Abi-Char; Tamara Coenen; Paul J Lijnen; Robert H Fagard; Karin R Sipido; Victor V Petrov
Journal:  Cardiovasc Res       Date:  2013-12-23       Impact factor: 10.787

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.